This inventor holds 2 USPTO granted patents. Top assignee: Parker Hughes Institute. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: **Inventor Profile: Vuoung N. Trieu**
Introduction
Vuoung N. Trieu is a notable inventor based in Roseville, Minnesota, who has contributed to advancements in medical treatments. With two patents to his name, he is focused on addressing serious health conditions through innovative methodologies. Currently, he works at the Parker Hughes Institute, a research institution that emphasizes the importance of pioneering medical research.
Latest Patents
Vuoung N. Trieu's most recent inventions include significant research on using estrogens for treating amyotrophic lateral sclerosis (ALS). His patented methods involve administering phytoestrogen, particularly genistein, to prevent and treat ALS. This work represents a pivotal step towards improving therapies for a debilitating disease that affects many individuals.
Career Highlights
Throughout his career, Vuoung has dedicated himself to exploring effective treatments that can enhance patient outcomes. His work within the Parker Hughes Institute showcases his commitment to harnessing the power of biology for therapeutic purposes. The impact of his innovations has the potential to benefit those suffering from ALS.
Collaborations
Vuoung N. Trieu has collaborated with esteemed colleagues in his research endeavors. Notable among them are Xing-Ping Liu and Fatih M. Uckun. This teamwork facilitates a rich exchange of ideas and fosters the development of innovative solutions to complex medical challenges.
Conclusion
The work of Vuoung N. Trieu illustrates the vital role of inventors in advancing science and medicine. Through his patents, he contributes to the ongoing fight against ALS and shows how innovative thinking can lead to promising therapies. As he continues his research at the Parker Hughes Institute, the potential for impactful discoveries remains high, showcasing the importance of continued investment in research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile